Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors

被引:19
|
作者
Kanamori, Masayuki [1 ]
Kumabe, Toshihiro [1 ]
Sonoda, Yukihiko [1 ]
Nishino, Yoshikazu [2 ]
Watanabe, Mika [3 ]
Tominaga, Teiji [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Natori, Miyagi 9811293, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808574, Japan
关键词
Oligodendroglioma; Dissemination; Predictive factors; Nestin Ki-67; LOW-GRADE OLIGODENDROGLIOMAS; PHASE-III TRIAL; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; GLIOMAS; CHEMOTHERAPY; RADIOTHERAPY; MARKERS; NESTIN;
D O I
10.1007/s11060-008-9762-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pattern of recurrence and predictive factors for tumor progression, dissemination and survival in oligodendroglial tumors were investigated. 56 consecutive patients with oligodendroglial tumors were retrospectively analyzed to determine the predictive significance of various factors, including World Health Organization grade, loss of chromosomes 1p and 19q, and immunohistochemical features of TP53, O-6-methylguanine-deoxyribonucleic-acid-methyltransferase, CD44H, nestin, and Ki-67. Eleven patients developed dissemination, and had significantly shorter post-progression survival compared to ten patients with local recurrence. Univariate analysis showed that retention of chromosome 1p or 19q, Ki-67 labeling index a parts per thousand yen 25%, diffuse expression of nestin, and p53 labeling index a parts per thousand yen 10% were unfavorable factors for overall, progression-free, and dissemination-free survival. Multivariate analysis showed that Ki-67 labeling index a parts per thousand yen 25% and diffuse expression of nestin were significant for dissemination-free survival. In conclusion, post-progression survival shows significant differences between patients with local and disseminated recurrence. Ki-67 labeling index and nestin expression pattern are useful markers to predict dissemination.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 50 条
  • [41] Joint modeling of progression-free and overall survival and computation of correlation measures
    Meller, Matthias
    Beyersmann, Jan
    Rufibach, Kaspar
    STATISTICS IN MEDICINE, 2019, 38 (22) : 4270 - 4289
  • [42] Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients
    Hogdall, Estrid
    Fung, Eric T.
    Christensen, Ib Jarle
    Yip, Christine
    Nedergaard, Lotte
    Engelholm, Svend Aage
    Risum, Signe
    Petri, Anette Lykke
    Lundvall, Lene
    Lomas, Lee
    Hogdall, Claus
    PROTEOMICS CLINICAL APPLICATIONS, 2010, 4 (12) : 940 - 952
  • [44] Progression-free or overall survival...revisited in BOLERO-2
    Gupta, Sudeep
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2014, 35 (01) : 1 - 2
  • [45] The Impact of Focal Lesions on Overall and Progression-free Survival in Multiple Myeloma
    Kirkizlar, Tugcan Alp
    Kirkizlar, Onur
    Soyluoglu, Selin
    Umit, Elif Gulsum
    Ustun, Funda
    Demir, Ahmet Muzaffer
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 39 (05): : 353 - 359
  • [46] Progression-free survival versus post-progression survival and overall survival in WHO grade 2 gliomas
    Sagberg, Lisa Millgard
    Salvesen, Oyvind
    Jakola, Asgeir Store
    Thurin, Erik
    de Dios, Eddie
    Nawabi, Noah L. A.
    Kilgallon, John L.
    Bernstock, Joshua D.
    Kavouridis, Vasileios K.
    Smith, Timothy R.
    Solheim, Ole
    ACTA ONCOLOGICA, 2024, 63 : 798 - 804
  • [47] Pre-operative hematological markers as predictive factors for overall survival and progression free survival in glioblastomas
    Marini, Alessandra
    Dobran, Mauro
    Aiudi, Denis
    Pesaresi, Alessandro
    di Somma, Lucia Giovanna Maria
    Iacoangeli, Maurizio
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2020, 197
  • [48] BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma
    Tabouret, E.
    Bequet, C.
    Denicolai, E.
    Barrie, M.
    Nanni, I.
    Metellus, P.
    Dufour, Henri
    Chinot, O.
    Figarella-Branger, D.
    EJSO, 2015, 41 (12): : 1685 - 1690
  • [49] PREDICTIVE MARKERS FOR OVERALL AND PROGRESSION-FREE SURVIVAL WITH CAPOX IN SECOND-LINE CHEMOTHERAPY OF METASTATIC COLORECTAL CANCER
    Solis Hernandez, M. D. P.
    Jimenez Fonseca, P.
    Perez, Q.
    Alvarez Fernandez, C.
    Ruiz, L.
    Rodriguez Rubi, D.
    Li, W.
    Sanchez, M. L.
    Faez, L.
    Vieitez, J. M.
    ANNALS OF ONCOLOGY, 2012, 23 : 218 - 218
  • [50] IS PROGRESSION-FREE SURVIVAL A GOOD INDICATOR OF OVERALL SURVIVAL FOR PAZOPANIB IN PATIENTS WITH SYNOVIAL SARCOMA?
    Han, J.
    Lee, S.
    Cho, E.
    VALUE IN HEALTH, 2022, 25 (12) : S489 - S490